cept Therapeutics rporated-Wall Street Analysts Think Corcept (CORT) Could Surge 37.91%: Read This Before Placing a Bet

Corcept Therapeutics (CORT) closed the last trading session at $54.31, gaining 11% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 74.90 indicates a 37.9% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $5.03. While the lowest estimate of$ 67 indicates a 23.4% increase from the current price level, the most optimistic analyst ...